Provided by Tiger Fintech (Singapore) Pte. Ltd.

BAIYUNSHAN PH

17.480
-0.020-0.11%
Volume:616.00K
Turnover:10.72M
Market Cap:28.42B
PE:9.41
High:17.480
Open:17.400
Low:17.240
Close:17.500
Loading ...

Baiyunshan Pharma's Subsidiary Gets Nod to Trial Yupingfeng Tea Bag as Treatment For Hypothyroidism

MT Newswires Live
·
26 Mar

Baiyunshan Pharmaceutical's Branch Gets Nod to Market Atorvastatin Calcium

MT Newswires Live
·
07 Mar

Baiyunshan Pharma's Unit Gets Regulatory Nod to Amend License

MT Newswires Live
·
06 Mar

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's (HKG:874) Low P/E No Reason For Excitement

Simply Wall St.
·
04 Mar

Guangzhou Baiyunshan Pharmaceutical - Disposal of Second New Underlying Assets of Gp Corp. to Industrial Securities Asset Management for RMB583.1 Mln

THOMSON REUTERS
·
28 Feb

BRIEF-Guangzhou Baiyunshan Pharmaceutical Received Written Resignation From Executive Director

Reuters
·
14 Feb

Guangzhou Baiyunshan Pharmaceutical - Received Written Resignation From Wu Changhai as Executive Director

THOMSON REUTERS
·
14 Feb

Guangzhou Baiyunshan Pharmaceutical Holdings (HKG:874) Has A Pretty Healthy Balance Sheet

Simply Wall St.
·
04 Feb

BRIEF-Guangzhou Baiyunshan Pharmaceutical Says Liu Juyan Resigns As Executive Director Of 9th Session

Reuters
·
21 Jan

Guangzhou Baiyunshan Pharmaceutical - Received Resignation From Liu Juyan as Executive Director of 9TH Session

THOMSON REUTERS
·
21 Jan

Baiyunshan Pharma's Venture Capital Fund Completes Registration

MT Newswires Live
·
08 Jan

There Are Reasons To Feel Uneasy About Guangzhou Baiyunshan Pharmaceutical Holdings' (HKG:874) Returns On Capital

Simply Wall St.
·
07 Jan

BRIEF-Guangzhou Baiyunshan Pharmaceutical Proposes To Appoint Li Xiaojun As An Executive Director Of 9Th Session

Reuters
·
23 Dec 2024

Guangzhou Baiyunshan Pharmaceutical - Proposes to Appoint Li Xiaojun as Executive Director

THOMSON REUTERS
·
23 Dec 2024

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (HKG:874) stock most popular amongst private companies who own 46%, while individual investors hold 36%

Simply Wall St.
·
17 Dec 2024

Baiyunshan Pharmaceutical's Unit Gets Nod to Cefuroxime Sodium for Injection's Amendment

MT Newswires Live
·
16 Dec 2024

Baiyunshan Pharma's Unit Gets Nod to Make Changes to Selaginella Jiangnanensis Tablets

MT Newswires Live
·
28 Nov 2024

Baiyunshan Pharma Gets Nod to Market Anti-Tumor Drug

MT Newswires Live
·
28 Nov 2024

Guangzhou Baiyunshan Pharmaceutical Holdings (HKG:874) investors are sitting on a loss of 9.5% if they invested five years ago

Simply Wall St.
·
23 Nov 2024

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Recorded A 7.9% Miss On Revenue: Analysts Are Revisiting Their Models

Simply Wall St.
·
30 Oct 2024